Your session is about to expire
← Back to Search
Native PATHS Program for Substance Use Prevention in Indigenous Youth
N/A
Recruiting
Led By Nichea S Spillane, Ph.D.
Research Sponsored by University of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Family Participants must be at least 18 years of age
Youth Participants must be in grades 5th - 8th at time of enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months following end of treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new program, Native PATHS, to see if it is more effective than a wait-list control condition in reducing risk factors for suicide among Indigenous youth.
Who is the study for?
This trial is for North American Indian adolescents in grades 5th - 8th and their influential family members who are at least 18 years old. Participants should be living within a First Nation community and identify as a member of that community. Only one youth per household can join, with the goal to help them make good decisions about substance use.
What is being tested?
The study is testing Native PATHS, an intervention aimed at preventing substance use among young people. It includes talking circles for feedback on cultural adaptation, an open label pilot for initial reactions, and finally a randomized controlled trial comparing the program's efficacy against waiting for treatment.
What are the potential side effects?
Since this trial focuses on prevention education rather than medication or medical procedures, traditional side effects aren't expected. However, participants may experience emotional discomfort discussing sensitive topics related to substance use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am at least 18 years old.
Select...
I am a student in grades 5 through 8.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ six months following end of treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months following end of treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Alcohol Use Disorder
Cigarette smoking susceptibility
Marijuana use intentions
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Native PATHS ConditionExperimental Treatment1 Intervention
A strengths-based, behavioral economic approach to increasing engagement and reinforcement for engaging in alternative activities.
Group II: Wait-List ControlActive Control1 Intervention
Participants will receive the Native PATHS program once 6-month follow up surveys have been completed.
Find a Location
Who is running the clinical trial?
University of Rhode IslandLead Sponsor
56 Previous Clinical Trials
22,311 Total Patients Enrolled
Nichea S Spillane, Ph.D.Principal InvestigatorUniversity of Rhode Island
1 Previous Clinical Trials
60 Total Patients Enrolled